About Abionyx

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones

Thanks to its partners in research, medicine, its bioproduct suppliers and its shareholders, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.

Latest press releases

Read more

FOCUS

Brain-Kidney Interplay during Sepsis- Associated AKI: Results from the RACERS Study

Inclusion of Patients in Racers Study Completed, Results Expected by Late-Autumn

Publication of RACERS data in BMC Medecine / Nature Springer - PDF

A new generation biotech company

Contribute to the development of innovative therapies for patients without existing or effective treatment

ABIONYX Pharma is a new generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones.

Thanks to its partners in research, medicine, biopharmaceuticals and shareholding, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.